Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOLL: Enoxaparin vs UFH in STEMI Patients Undergoing Primary PCI
NCT00718471Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2008
- Primary completion
- Mar 2010
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in myocardial infarction (MI), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2008; status: completed.
02
Drugs
enoxaparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00718471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718471.